Miranda Durkie

1.1k total citations
20 papers, 320 citations indexed

About

Miranda Durkie is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Miranda Durkie has authored 20 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Miranda Durkie's work include Renal and related cancers (6 papers), Genomics and Rare Diseases (5 papers) and Genetic and Kidney Cyst Diseases (5 papers). Miranda Durkie is often cited by papers focused on Renal and related cancers (6 papers), Genomics and Rare Diseases (5 papers) and Genetic and Kidney Cyst Diseases (5 papers). Miranda Durkie collaborates with scholars based in United Kingdom, Ireland and United States. Miranda Durkie's co-authors include Albert Ong, Patricia A. Jacobs, Sheila Youings, Manoj K. Valluru, Peter C. Harris, N. Simon Thomas, Nicholas R. Dennis, I. R. Peake, Diana Curtis and Anne Goodeve and has published in prestigious journals such as The American Journal of Human Genetics, Transplantation and British Journal of Haematology.

In The Last Decade

Miranda Durkie

18 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda Durkie United Kingdom 9 170 142 63 54 45 20 320
Fumio Endo Japan 9 54 0.3× 95 0.7× 106 1.7× 85 1.6× 45 1.0× 10 288
Han Wook Yoo South Korea 10 87 0.5× 116 0.8× 142 2.3× 99 1.8× 42 0.9× 50 416
Fatma Al‐Jasmi United Arab Emirates 10 77 0.5× 103 0.7× 28 0.4× 24 0.4× 10 0.2× 20 280
Xuen Yu China 8 26 0.2× 129 0.9× 77 1.2× 62 1.1× 17 0.4× 23 290
Nechama Shalva Israel 5 64 0.4× 111 0.8× 66 1.0× 29 0.5× 13 0.3× 8 190
Zhengqing Qiu China 10 96 0.6× 78 0.5× 26 0.4× 20 0.4× 9 0.2× 40 273
Connie Lund Denmark 8 61 0.4× 183 1.3× 276 4.4× 107 2.0× 54 1.2× 8 407
Caroline M. McKinnon United Kingdom 8 205 1.2× 329 2.3× 12 0.2× 16 0.3× 12 0.3× 13 602
Fengxia Yao China 11 94 0.6× 153 1.1× 26 0.4× 20 0.4× 13 0.3× 31 270
Elena Bueno‐Martínez Spain 12 174 1.0× 233 1.6× 21 0.3× 13 0.2× 4 0.1× 28 537

Countries citing papers authored by Miranda Durkie

Since Specialization
Citations

This map shows the geographic impact of Miranda Durkie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Durkie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Durkie more than expected).

Fields of papers citing papers by Miranda Durkie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Durkie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Durkie. The network helps show where Miranda Durkie may publish in the future.

Co-authorship network of co-authors of Miranda Durkie

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Durkie. A scholar is included among the top collaborators of Miranda Durkie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Durkie. Miranda Durkie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowlands, Charlie F, Alice Garrett, Miranda Durkie, et al.. (2025). Availability of benign missense variant “truthsets” for validation of functional assays: Current status and a systematic approach. The American Journal of Human Genetics. 112(10). 2281–2294.
2.
Kershaw, Christopher J., Leigh Demain, George J. Burghel, et al.. (2025). Whole Genome Sequencing to Identify Novel Germline Fumarate Hydratase Mutation in Child With Bilateral Renal Cell Carcinoma. Clinical Genetics. 107(6). 702–704.
3.
McVeigh, Terri, Fiona Lalloo, Ian M. Frayling, et al.. (2024). Challenges in developing and implementing international best practice guidance for intermediate-risk variants in cancer susceptibility genes: APC c.3920T>A p.(Ile1307Lys) as an exemplar. Journal of Medical Genetics. 61(8). 810–812. 4 indexed citations
4.
McVeigh, Terri, Fiona Lalloo, Kevin Monahan, et al.. (2024). Carrier testing for partners of MUTYH variant carriers: UK Cancer Genetics Group recommendations. Journal of Medical Genetics. 61(8). 813–816. 1 indexed citations
5.
McDevitt, Trudi, Miranda Durkie, Norbert Arnold, et al.. (2024). EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer. European Journal of Human Genetics. 32(5). 479–488. 5 indexed citations
6.
Rowlands, Charlie F, Alice Garrett, Miranda Durkie, et al.. (2024). The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification. Journal of Medical Genetics. 61(10). 983–991. 1 indexed citations
7.
8.
Valluru, Manoj K., et al.. (2024). Combining genotype with height-adjusted kidney length predicts rapid progression of ADPKD. Nephrology Dialysis Transplantation. 39(6). 956–966. 4 indexed citations
9.
Durkie, Miranda, Christopher M. Watson, Peter R. Winship, et al.. (2023). The Common PKD1 p.(Ile3167Phe) Variant Is Hypomorphic and Associated with Very Early Onset, Biallelic Polycystic Kidney Disease. Human Mutation. 2023. 1–8. 2 indexed citations
10.
Hanson, Helen, Miranda Durkie, Fiona Lalloo, et al.. (2022). UK recommendations for SDHA germline genetic testing and surveillance in clinical practice. Journal of Medical Genetics. 60(2). 107–111. 10 indexed citations
11.
Çubuk, Cankut, Alice Garrett, Laura King, et al.. (2021). Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes. Genetics in Medicine. 23(11). 2096–2104. 42 indexed citations
12.
Durkie, Miranda, et al.. (2020). Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney disease. Genetics in Medicine. 23(4). 689–697. 40 indexed citations
13.
Garrett, Alice, Miranda Durkie, Alison Callaway, et al.. (2020). Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations. Journal of Medical Genetics. 58(5). 297–304. 36 indexed citations
14.
Watson, Mark B., John A. Snowden, Gill Wilson, et al.. (2016). Lineage‐specific chimerism monitoring after allogeneic haematopoietic stem cell transplantation: do we really know what we are measuring?. British Journal of Haematology. 176(1). 139–141. 2 indexed citations
15.
Simms, Roslyn, et al.. (2014). Genetic Testing in the Assessment of Living Related Kidney Donors at Risk of Autosomal Dominant Polycystic Kidney Disease. Transplantation. 99(5). 1023–1029. 16 indexed citations
16.
Thorburn, David R., et al.. (2013). Fumarase Deficiency in Dichorionic Diamniotic Twins. Twin Research and Human Genetics. 16(6). 1117–1120. 6 indexed citations
17.
Crushell, Ellen, et al.. (2010). Glycogen storage disease type III in the Irish population. Journal of Inherited Metabolic Disease. 33(S3). 215–218. 13 indexed citations
18.
Thomas, N. Simon, Miranda Durkie, Richard Sandford, et al.. (2006). Parental and chromosomal origins of microdeletion and duplication syndromes involving 7q11.23, 15q11-q13 and 22q11. European Journal of Human Genetics. 14(7). 831–837. 35 indexed citations
19.
Thomas, N. Simon, et al.. (2006). Parental and chromosomal origin of unbalanced de novo structural chromosome abnormalities in man. Human Genetics. 119(4). 444–450. 37 indexed citations
20.
Curtis, Diana, Miranda Durkie, Anne Goodeve, et al.. (1999). A study of Wilson disease mutations in Britain. Human Mutation. 14(4). 304–311. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumio Endo Breakdown of academic impact, for papers by Han Wook Yoo Breakdown of academic impact, for papers by Fatma Al‐Jasmi Breakdown of academic impact, for papers by Xuen Yu Breakdown of academic impact, for papers by Nechama Shalva Breakdown of academic impact, for papers by Zhengqing Qiu Breakdown of academic impact, for papers by Connie Lund Breakdown of academic impact, for papers by Caroline M. McKinnon Breakdown of academic impact, for papers by Fengxia Yao Breakdown of academic impact, for papers by Elena Bueno‐Martínez
Rankless by CCL
2026